Stocks Overview

LAST PRICE
28.2400
TODAY'S CHANGE (%)
Trending Down-0.1400 (-0.4933%)

Bid / Lots
27.9000/ 1
Ask / Lots
28.5700/ 1
Open / Previous Close
28.2300 / 28.3800
Day Range
Low 28.0500
High 28.3100
52 Week Range
Low 25.2000
High 31.6550
Volume
1,391,211
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 28.38
Time	Volume	RPRX
09:32 ET	16602	28.21
09:34 ET	12159	28.21
09:36 ET	2296	28.11
09:38 ET	986	28.145
09:39 ET	610	28.15
09:41 ET	1313	28.06
09:43 ET	1946	28.09
09:45 ET	1114	28.0856
09:48 ET	2102	28.06
09:50 ET	11848	28.13
09:52 ET	3662	28.185
09:54 ET	1221	28.185
09:56 ET	6762	28.22
09:57 ET	929	28.28
09:59 ET	5702	28.245
10:01 ET	4679	28.245
10:03 ET	5135	28.27
10:06 ET	3444	28.255
10:08 ET	7328	28.255
10:10 ET	4585	28.245
10:12 ET	1718	28.265
10:14 ET	10043	28.23
10:15 ET	2150	28.21
10:17 ET	931	28.21
10:19 ET	4099	28.185
10:21 ET	1906	28.19
10:24 ET	6077	28.11
10:26 ET	2961	28.12
10:28 ET	3188	28.08
10:30 ET	14339	28.075
10:32 ET	3792	28.07
10:33 ET	1684	28.11
10:35 ET	8410	28.175
10:37 ET	6825	28.165
10:39 ET	2520	28.16
10:42 ET	2791	28.21
10:44 ET	3102	28.205
10:46 ET	1599	28.225
10:48 ET	2200	28.235
10:50 ET	2339	28.245
10:51 ET	7384	28.235
10:53 ET	3809	28.23
10:55 ET	4314	28.225
10:57 ET	1119	28.23
11:00 ET	3154	28.195
11:02 ET	3547	28.21
11:04 ET	2168	28.245
11:06 ET	1850	28.255
11:08 ET	3326	28.245
11:09 ET	3122	28.24
11:11 ET	1994	28.235
11:13 ET	7063	28.21
11:15 ET	2141	28.175
11:18 ET	3879	28.18
11:20 ET	2018	28.175
11:22 ET	1894	28.21
11:24 ET	3482	28.185
11:26 ET	6036	28.17
11:27 ET	4170	28.185
11:29 ET	5072	28.205
11:31 ET	709	28.225
11:33 ET	9225	28.255
11:36 ET	1242	28.245
11:38 ET	13845	28.3075
11:40 ET	6163	28.255
11:42 ET	3018	28.275
11:44 ET	3874	28.28
11:45 ET	1643	28.295
11:47 ET	4717	28.28
11:49 ET	2523	28.285
11:51 ET	2195	28.27
11:54 ET	2797	28.255
11:56 ET	7472	28.295
11:58 ET	4383	28.285
12:00 ET	2416	28.265
12:02 ET	4739	28.26
12:03 ET	1394	28.26
12:05 ET	7451	28.255
12:07 ET	6555	28.265
12:09 ET	3728	28.255
12:12 ET	3061	28.255
12:14 ET	10165	28.255
12:16 ET	7828	28.25
12:18 ET	6833	28.255
12:20 ET	4712	28.255
12:21 ET	1575	28.255
12:23 ET	1947	28.255
12:25 ET	12755	28.245
12:27 ET	2559	28.255
12:30 ET	1884	28.275
12:32 ET	10851	28.265
12:34 ET	1411	28.27
12:36 ET	1425	28.255
12:38 ET	2906	28.225
12:39 ET	1000	28.205
12:41 ET	696	28.225
12:43 ET	1155	28.215
12:45 ET	1608	28.21
12:48 ET	1214	28.215
12:50 ET	3735	28.2
12:52 ET	3604	28.215
12:54 ET	1080	28.22
12:56 ET	801	28.23
12:57 ET	1922	28.225
12:59 ET	1549	28.225
01:01 ET	200	28.22
01:03 ET	1793	28.225
01:06 ET	100	28.22
01:08 ET	3112	28.205
01:10 ET	3185	28.205
01:12 ET	913	28.205
01:14 ET	1635	28.205
01:15 ET	724	28.205
01:17 ET	3155	28.2
01:19 ET	1524	28.215
01:21 ET	200	28.215
01:24 ET	1774	28.215
01:26 ET	800	28.215
01:28 ET	3355	28.21
01:30 ET	7605	28.225
01:32 ET	3777	28.22
01:33 ET	932	28.225
01:35 ET	1467	28.23
01:37 ET	1000	28.25
01:39 ET	684	28.26
01:42 ET	3631	28.245
01:44 ET	1984	28.22
01:46 ET	1839	28.245
01:48 ET	4746	28.22
01:50 ET	2732	28.245
01:51 ET	1418	28.245
01:53 ET	253	28.245
01:55 ET	2749	28.245
01:57 ET	5085	28.245
02:00 ET	2007	28.25
02:02 ET	6841	28.255
02:04 ET	770	28.255
02:06 ET	1398	28.26
02:08 ET	9060	28.245
02:09 ET	1417	28.255
02:11 ET	2734	28.2497
02:13 ET	1000	28.24
02:15 ET	2873	28.255
02:18 ET	1037	28.26
02:20 ET	4384	28.245
02:22 ET	3957	28.245
02:24 ET	1555	28.24
02:26 ET	3863	28.245
02:27 ET	10164	28.245
02:29 ET	884	28.245
02:31 ET	849	28.25
02:33 ET	3976	28.255
02:36 ET	1794	28.255
02:38 ET	493	28.25
02:40 ET	900	28.255
02:42 ET	2573	28.25
02:44 ET	2586	28.265
02:45 ET	7710	28.255
02:47 ET	690	28.265
02:49 ET	4557	28.275
02:51 ET	2047	28.275
02:54 ET	4053	28.285
02:56 ET	4938	28.29
02:58 ET	1400	28.295
03:00 ET	1768	28.3
03:02 ET	9444	28.255
03:03 ET	4061	28.265
03:05 ET	1400	28.275
03:07 ET	5136	28.265
03:09 ET	2865	28.255
03:12 ET	3600	28.275
03:14 ET	2976	28.285
03:16 ET	6377	28.285
03:18 ET	5133	28.305
03:20 ET	3741	28.295
03:21 ET	7025	28.3
03:23 ET	6910	28.2893
03:25 ET	2143	28.255
03:27 ET	2827	28.265
03:30 ET	904	28.255
03:32 ET	2621	28.235
03:34 ET	3589	28.2399
03:36 ET	2614	28.215
03:38 ET	4899	28.23
03:39 ET	2427	28.235
03:41 ET	10751	28.24
03:43 ET	4730	28.23
03:45 ET	5141	28.215
03:48 ET	6325	28.22
03:50 ET	6686	28.21
03:52 ET	7707	28.235
03:54 ET	12321	28.25
03:56 ET	27245	28.26
03:57 ET	20349	28.25
03:59 ET	260993	28.24

Data delayed at least 15 minutes.

Sep 20, 2024
- DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones
  7:30AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 18, 2024
- DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
- Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Press Release: Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.8B	18.8x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.7B	-13.8x	---
United StatesNDOI Endo Inc	1.9B	0.4x	---
United StatesCTLT Catalent Inc	10.9B	-10.5x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.7B	18.8x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
As of 2024-10-02

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Head of Human Capital: Molly Sawaya

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.8B
Revenue (TTM)	$2.2B
Shares Outstanding	593.5M
Dividend Yield	2.97%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	08-16-24
Pay Date	09-13-24
Beta	0.46
EPS	$1.50
Book Value	$14.61
P/E Ratio	18.8x
Price/Sales (TTM)	7.5
Price/Cash Flow (TTM)	20.1x
Operating Margin	42.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Sep 20, 2024

DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones

Sep 18, 2024

DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 3, 2024

Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Press Release: Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar